Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Acute Graft-Versus-Host Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04567810
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Chicken Egg Antibody (IgY) (COVID-19)

Who this might be right for
Covid19
Stanford University 48
Testing effectiveness (Phase 2)Study completedNCT01583738
What this trial is testing

Effect of V0251 in Acute Vertigo

Who this might be right for
Acute Vertigo
Pierre Fabre Medicament 132
Not applicableLooking for participantsNCT07188038
What this trial is testing

The Impact of Low Versus High Positive End-expiratory Pressure on Diaphragm Function, Ventilation Efficiency, and Lung Mechanics

Who this might be right for
Respiratory FailureARDS (Acute Respiratory Distress Syndrome)Pneumonia+1 more
Vastra Gotaland Region 25
Testing effectiveness (Phase 2)Study completedNCT00797758
What this trial is testing

Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Assistance Publique - Hôpitaux de Paris 76
Not applicableStudy completedNCT04477655
What this trial is testing

Prone Positioning in Non-intubated Patients With COVID-19 Associated Acute Respiratory Failure

Who this might be right for
Covid19
Hospital Civil de Guadalajara 430
Large-scale testing (Phase 3)Study completedNCT00457015
What this trial is testing

Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE)

Who this might be right for
Hereditary Angioedema (HAE)
Shire 96
Not applicableStudy completedNCT01626235
What this trial is testing

AMPED Outcomes Registry of Post-ED Pain Management

Who this might be right for
Soft Tissue InjuriesGouty ArthritisFractures+2 more
Radnor Registry Research, Inc 843
Not applicableStudy completedNCT05538117
What this trial is testing

Diagnostic Performance of Coronary Calcification Detection on CT Scan

Who this might be right for
Acute Coronary Syndrome
University Hospital, Strasbourg, France 300
Not applicableStudy completedNCT01684540
What this trial is testing

Application of Ectoin® Rhinitis Nasal Spray in Patients With Acute Rhinosinusitis

Who this might be right for
Sinusitis
Bitop AG 66
Not applicableUnknownNCT04411368
What this trial is testing

Impact of Respiratory Virus in Critically Ill Patients With Acute Respiratory Failure

Who this might be right for
Acute Respiratory FailureAcute Respiratory Distress Syndrome
Seoul St. Mary's Hospital 540
Not applicableLooking for participantsNCT06081218
What this trial is testing

Effect of Acute Exercise on Cognitive Functions and Blood Markers of Brain Plasticity in Regular Chronic Cannabis Users

Who this might be right for
Cannabis User
University Hospital, Lille 60
Post-approval studies (Phase 4)Ended earlyNCT00894790
What this trial is testing

Celecoxib Efficacy And Safety Versus Diclofenac In Acute Pain Due To Cervical Sprain Related To A Traffic Accident

Who this might be right for
Pain
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 8
Testing effectiveness (Phase 2)Study completedNCT00093197
What this trial is testing

Safety of KAI-9803 for Injection With Angioplasty Following Heart Attack

Who this might be right for
Myocardial Infarction
KAI Pharmaceuticals 154
Large-scale testing (Phase 3)Looking for participantsNCT05726110
What this trial is testing

Selinexor in Combination With HAD or CAG Rregimens in Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
Shanxi Bethune Hospital 50
Testing effectiveness (Phase 2)WithdrawnNCT04725110
What this trial is testing

Direct Topical Lung T3 Treatment to Improve Outcome & Sequelae of COVID-19 Acute Respiratory Distress Syndrome

Who this might be right for
Covid19SARS-CoV InfectionARDS+1 more
University of Minnesota
Not applicableNot Yet RecruitingNCT06276413
What this trial is testing

REgistRy BRAnch goRE EndopRosthEsis

Who this might be right for
Aortic Aneurysm, ThoracicAortic Dissection
University Hospital Padova 50
Testing effectiveness (Phase 2)UnknownNCT02347358
What this trial is testing

Mechanical Opening Device Implantation Following Intravenous r-tPA for Recanalization in Acute Ischemic Stroke

Who this might be right for
Ischemic Cerebrovascular Accident
The Second Artillery General Hospital 100
Post-approval studies (Phase 4)Study completedNCT02105155
What this trial is testing

Conversion Prograf® to Advagraf® at D7 Versus D90 After Liver Transplantation

Who this might be right for
Immunosuppression After Liver Transplantation
Assistance Publique - Hôpitaux de Paris 90
Not applicableNot Yet RecruitingNCT07484178
What this trial is testing

Effectiveness of Nurse-Led Interventions on Respiratory Outcomes in Hospitalized Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Who this might be right for
Acute Exacerbation Copd
University of Health Sciences Lahore 68
Testing effectiveness (Phase 2)Study completedNCT00065143
What this trial is testing

Clofarabine Plus Cytarabine in Patients With Previously Untreated Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Who this might be right for
Leukemia, MyeloidMyelodysplastic Syndromes
M.D. Anderson Cancer Center 60
Next Page